Correlation Between Teva Pharma and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharma Industries and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Teva Pharma and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Crinetics Pharmaceuticals.
Diversification Opportunities for Teva Pharma and Crinetics Pharmaceuticals
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Teva and Crinetics is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Teva Pharma i.e., Teva Pharma and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Teva Pharma and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Teva Pharma is expected to generate 1.33 times less return on investment than Crinetics Pharmaceuticals. But when comparing it to its historical volatility, Teva Pharma Industries is 1.69 times less risky than Crinetics Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,779 in Crinetics Pharmaceuticals on November 30, 2024 and sell it today you would earn a total of 1,542 from holding Crinetics Pharmaceuticals or generate 86.68% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Teva Pharma Industries vs. Crinetics Pharmaceuticals
Performance |
Timeline |
Teva Pharma Industries |
Crinetics Pharmaceuticals |
Teva Pharma and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Teva Pharma and Crinetics Pharmaceuticals
The main advantage of trading using opposite Teva Pharma and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.Teva Pharma vs. Haleon plc | Teva Pharma vs. Bausch Health Companies | Teva Pharma vs. Zoetis Inc | Teva Pharma vs. Takeda Pharmaceutical Co |
Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |